Skip to main content
. 2022 Aug 2;15:43–57. doi: 10.2147/AABC.S366431

Figure 6.

Figure 6

Result of immune response simulation revealed that the final vaccine has the potential to induce antibody-mediated humoral immunity (A), CD8+ T Cell immune response (B), CD4+ T cell immune response (C) and non-specific immune response mediated by cytokines production (D).